Quest Diagnostics (DGX) financial statements

+64.6%since 2007
FY2025 revenue
$11.0B▲ +11.8%
FY2025 net income
$992M▲ +13.9%
FY2025 diluted EPS
$8.75▲ +13.8%
FY2025 free cash flow
$1.4B▲ +49.5%

Quest Diagnostics income statement

Quest Diagnostics income statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Revenue11,0359,8729,252
Operating income1,5561,3461,262
Pretax income1,3181,1751,130
Net income992871854
Diluted earnings per share8.757.697.49

Quest Diagnostics balance sheet

Quest Diagnostics balance sheet
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Cash and cash equivalents420549686
Total assets16,22516,15314,022
Total liabilities (derived)8,9399,2577,604
Total equity7,2066,8136,342
Long-term debt5,1675,6154,410

Quest Diagnostics cash flow statement

Quest Diagnostics cash flow statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Operating cash flow1,8861,3341,272
Capital expenditure-527-425-408
Free cash flow (derived)1,359909864
Dividends paid-353-331-314
Share repurchases-450-151-275

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended30 Sep 202630 Jun 202631 Mar 202631 Dec 2025
Revenue (derived)3,0973,0432,8952,806
Operating income (derived)479459399386
Net income (derived)312320252245
Diluted earnings per share2.782.842.24n/a
Operating cash flow (derived)611597278465
Total assets17,22116,93916,67316,225

Quest Diagnostics major shareholders

Quest Diagnostics major shareholders
HolderShare of classSharesFiled
BlackRock, Inc.8.4%9,308,81517 April 2025
Vanguard Capital Management7.5%8,274,56730 April 2026
Vanguard Portfolio Management5.5%6,096,62929 April 2026

Quest Diagnostics 10-K and SEC filings

Quest Diagnostics 10-K and SEC filings
FiledFormTypeDescription
23 October 202610-QQuarterly reportQuarterly report
22 October 20268-KCurrent reportCURRENT REPORT
22 October 20268-KCurrent reportCurrent report
6 October 20268-KCurrent reportCURRENT REPORT
23 July 202610-QQuarterly reportQuarterly report
23 July 20268-KCurrent reportCurrent report
21 May 20268-KCurrent reportCurrent report
8 May 20268-KCurrent reportFORM 8-K

Common questions

What was Quest Diagnostics' revenue in fiscal 2025?

Quest Diagnostics reported $11.0 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 11.8% from fiscal 2024.

What was Quest Diagnostics' net income in fiscal 2025?

Quest Diagnostics reported net income of $992 million for fiscal 2025, the year ended 31 December 2025, up 13.9% from fiscal 2024. Diluted earnings per share were $8.75.

What was Quest Diagnostics' free cash flow in fiscal 2025?

Quest Diagnostics had $1.4 billion in free cash flow in fiscal 2025. Operating cash flow was $1.9 billion and capital expenditure was $527 million.

What were Quest Diagnostics' total assets at the end of fiscal 2025?

Quest Diagnostics reported total assets of $16.2 billion at the end of fiscal 2025, the year ended 31 December 2025.

How much Quest Diagnostics history do I get?

Every account gets the full history, annual and quarterly, with first reported values and as of dates.